![]()
|
|
||||||||
J. Biol. Chem., Vol. 282, Issue 7, 4757-4764, February 16, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1
1




2
From the
Department of Physiology and Program in Molecular and Cellular Neuroscience, School of Dentistry and Dental Research Institute, Seoul National University, Seoul 110-749, Korea, the
Department of Physiology, College of Medicine, Kangwon National University, Chunchon 200-710, Korea, the ¶Département de Physiologie, Institut de Génomique Fonctionnelle, CNRS-UMR 5203 141, Rue de la Cardonille 34396 Montpellier Cedex 5, France, and the ||Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611
Cav2.3 calcium channels play an important role in pain transmission in peripheral sensory neurons. Six Cav2.3 isoforms resulting from different combinations of three inserts (inserts I and II in the IIIII loop and insert III in the carboxyl-terminal region) have been identified in different mammalian tissues. To date, however, Cav2.3 isoforms unique to primary sensory neurons have not been identified. In this study, we determined Cav2.3 isoforms expressed in the rat trigeminal ganglion neurons. Whole tissue reverse transcription (RT)-PCR analyses revealed that only two isoforms, Cav2.3a and Cav2.3e, are present in TG neurons. Using single cell RT-PCR, we found that Cav2.3e is the major isoform, whereas Cav2.3e expression is highly restricted to small (<16 µm) isolectin B4-negative and tyrosine kinase A-positive neurons. Cav2.3e was also preferentially detected in neurons expressing the nociceptive marker, transient receptor potential vanilloid 1. Single cell RT-PCR following calcium imaging and whole-cell patch clamp recordings provided evidence of an association between an R-type calcium channel component and Cav2.3e expression. Our results suggest that Cav2.3e in sensory neurons may be a potential target for the treatment of pain.
Received for publication, June 1, 2006 , and in revised form, November 27, 2006.
* This work was supported by MOEHRD Grant KRF-2003-003-E00207 from the Korea Research Foundation, Grant R01-2004-000-10384-0 from the Basic Research Program of the Korea Science and Engineering Foundation, and Grant M103KV010015-06K2201-01510 from Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Science and Technology, Republic of Korea. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Both authors contributed equally to this work.
2 To whom correspondence should be addressed. Tel.: 82-2-740-8656; Fax: 82-2-762-5107; E-mail: odolbae{at}snu.ac.kr.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. Chung, J.N. Rhee, S.J. Jung, J.S. Kim, and S.B. Oh Modulation of CaV2.3 Calcium Channel Currents by Eugenol J. Dent. Res., February 1, 2008; 87(2): 137 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.Y. Li, C.-K. Park, S.J. Jung, S.-Y. Choi, S.J. Lee, K. Park, J.S. Kim, and S.B. Oh Eugenol Inhibits K+ Currents in Trigeminal Ganglion Neurons J. Dent. Res., September 1, 2007; 86(9): 898 - 902. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |